Clinical Trials Browser

Interventional × Non-small Lung Cancer × toripalimab × Clear all

NCT06293690 2025-12-18

Toripalimab Combined With SBRT for NSCLC

Phase 2 Active not recruiting

Non-small Lung Cancer